日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / State Council News

Nation issues new anti-monopoly guidelines for pharma sector

By Li Jiaying | chinadaily.com.cn | Updated: 2025-01-24 21:04
Share
Share - WeChat
Pharmacists dispense drugs at a hospital in Huzhou, Zhejiang province, in August. YI FAN/FOR CHINA DAILY

In an effort to safeguard fair market competition and protect consumer interests, the State Council's anti-monopoly commission officially issued new anti-monopoly guidelines on Friday targeting the pharmaceutical sector. 

A key highlight of the guidelines lies in the involvement of online platforms' monopolistic regulations. Given the rapid growth of online medical consultations and pharmaceutical e-commerce, the guidelines, for the first time, incorporate measures to address monopolistic practices in online medicine businesses, prohibiting platforms from engaging in the misuse of data, algorithms or platform rules.

The broad scope of the new guidelines also merits attention, which encompasses the entire pharmaceutical product chain — including traditional Chinese medicine, chemical drugs and biological products — compared to the previous version, which was largely concentrated in the limited realm of chemical active pharmaceutical ingredients (APIs).

"The pharmaceutical industry is highly technology-driven. Besides APIs, it also includes innovative drugs, patented medicines and generics. Every stage — from procurement and R&D to production, distribution and generic development — involves significant technological advancements and related protective strategies," said Zhou Wei, deputy director of the health law research center at Wuhan University, in an earlier interview. 

To further combat "false innovation", the guidelines also address a new type of patent monopoly behavior known as "product hopping". 

Product hopping refers to a strategy employed by original drug manufacturers to avoid or reduce competition from generic drugs, which mostly occurs shortly before the expiration of a patented drug and the entry of its generic counterpart and if applied inappropriately, could constitute an abuse of market dominance.

Factors for evaluation include whether the new patented drug represents a non-substantial improvement and whether the transition hinders or delays the entry of generics into the market, according to the guidelines.

"This is not about restricting the development of patented drugs but about regulating false innovation that fails to significantly improve a drug's efficacy, safety or utility," Zhou said.

Comprising seven chapters and 55 articles, the guidelines aim to provide detailed interpretations of monopolistic practices, enforcement principles and criteria for determining violations, offering a comprehensive framework to tackle anti-competitive behaviors in the pharmaceutical industry.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 在线观看a视频 | 国产精品自拍在线观看 | 五月激情综合网 | 天天干天天拍天天操 | 国产aaaaa一级毛片 | 久久精品中文 | 狠狠色噜噜狠狠狠狠97老肥女 | 女人一级毛片免费视频观看 | 亚洲国产片高清在线观看 | 午夜激情小视频 | 久久久成人精品视频 | 精品国产一区二区三区免费 | 超碰一区二区三区 | 污视频在线免费播放 | 国产亚洲精品久久一区二区三区 | 日本一区二区三区精品国产 | 亚洲三级视频 | 91免费国产在线观看 | 午夜在线电影 | 午夜日韩| 中文字幕日韩欧美一区二区三区 | 九九在线精品视频播放 | 舒淇三级浴室洗澡在线观看 | 国内久久精品 | 五月激情六月婷婷 | 日韩欧美在线观看视频一区二区 | 最新精品在线 | 欧美成人午夜 | 久草经典视频 | 国产无遮挡一级毛片 | 久草免费资源视频 | 91免费在线看 | 欧美影院 | 二区国产 | 婷婷 综合网站 | 奇米影视888狠狠狠777九色 | 国产在线观看中文字幕 | 美国成人a免费毛片 | 精品一区二区电影 | 亚洲精品国产福利在线观看 | 企鹅公装网 |